49401-102 : Benlysta 400 mg/5ml Intravenous Injection, Powder, Lyophilized, for Solution


NDC: 49401-102
Labeler: Human Genome Sciences, Inc.
Product Type: Human Prescription Drug
Drug Name:  Benlysta
Dosage Form: Intravenous Injection, Powder, Lyophilized, for Solution
Application #: BLA125370
Rev. Date: 


NDC Package Codes:

  • 49401-102-01: 1 VIAL IN 1 CARTON (49401‑102‑01) > 5 ML IN 1 VIAL

Active Ingredients:

  • Belimumab

Dosage Strength:

  • 400 mg/5mL

Pharmaceutical Classes:

  • Decreased B Lymphocyte Activation [PE]
  • B Lymphocyte Stimulator-specific Inhibitor [EPC]
  • B Lymphocyte Stimulator-directed Antibody Interactions [MoA]

Related Products:

Based on records with the same trade name.
  • 49401-088 Benlysta 200 mg/ml Subcutaneous Solution by Human Genome Sciences, Inc.
  • 49401-101 Benlysta 120 mg/1.5ml Intravenous Injection, Powder, Lyophilized, for Solution by Human Genome Sciences, Inc.
  • 12064-009 Benlysta 120 mg/1.5ml Intravenous Injection, Powder, Lyophilized, for Solution by Glaxosmithkline Manufacturing Spa
  • 12064-010 Benlysta 400 mg/5ml Intravenous Injection, Powder, Lyophilized, for Solution by Glaxosmithkline Manufacturing Spa

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 49401-102 QR Code

< Prev: 49401-101Next: 49401-103 >

Related Discussions:

Migraines associated to Benlysta use?
I am going for my fourth Benlysta treatment tomorrow and although I've noticed huge differences in my mobility and j... 10 replies




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.